Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2018-03-24
DOI
10.1080/10428194.2018.1452213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential for subsets of wt-NPM1 primary AML blasts to respond to retinoic acid treatment
- (2017) Rodica P. Bunaciu et al. Oncotarget
- Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout
- (2017) Robert J. MacDonald et al. Scientific Reports
- Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation
- (2016) Noriyoshi Iriyama et al. Cancer Cell International
- Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib
- (2016) Richat Abbas et al. CLINICAL PHARMACOKINETICS
- A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity
- (2016) Sophia Hu et al. MOLECULAR CANCER THERAPEUTICS
- RRD-251 enhances all-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells
- (2016) Aaron S. Wallace et al. Oncotarget
- GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation
- (2015) Holly A. Jensen et al. CELLULAR SIGNALLING
- Acute promyelocytic leukemia: where did we start, where are we now and the future
- (2015) C C Coombs et al. Blood Cancer Journal
- The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells
- (2015) Christopher N. Ibabao et al. FEBS Open Bio
- Acute promyelocytic leukemia: What is the new standard of care?
- (2014) Justin M. Watts et al. BLOOD REVIEWS
- Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity
- (2014) Johanna Congleton et al. CELLULAR SIGNALLING
- Proliferation and Survival Signaling from Both Jak2-V617F and Lyn Involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 Cell Line Newly Established from Acute Myeloid Leukemia Transformed from Polycythemia Vera
- (2014) Toshikage Nagao et al. PLoS One
- Retinoic Acid Therapy Resistance Progresses from Unilineage to Bilineage in HL-60 Leukemic Blasts
- (2014) Holly A. Jensen et al. PLoS One
- Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors
- (2013) H. M. Kantarjian et al. BLOOD
- 6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells
- (2013) Rodica P Bunaciu et al. Molecular Cancer
- The Src-Family Kinase Inhibitor PP2 Rescues Inducible Differentiation Events in Emergent Retinoic Acid-Resistant Myeloblastic Leukemia Cells
- (2013) Holly A. Jensen et al. PLoS One
- Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
- (2012) J. S. Logue et al. GENES & DEVELOPMENT
- Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
- (2011) J. E. Cortes et al. BLOOD
- Activation of the Aryl Hydrocarbon Receptor AhR Promotes Retinoic Acid-Induced Differentiation of Myeloblastic Leukemia Cells by Restricting Expression of the Stem Cell Transcription Factor Oct4
- (2011) R. P. Bunaciu et al. CANCER RESEARCH
- Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells
- (2011) J Congleton et al. LEUKEMIA
- Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias
- (2010) B. S. Guerrouahen et al. CLINICAL CANCER RESEARCH
- Dasatinib promotes ATRA-induced differentiation of AML cells
- (2009) P L Kropf et al. LEUKEMIA
- c-Cbl Interacts with CD38 and Promotes Retinoic Acid–Induced Differentiation and G0Arrest of Human Myeloblastic Leukemia Cells
- (2008) Miaoqing Shen et al. CANCER RESEARCH
- Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis
- (2008) M. P. Kim et al. CELL AND TISSUE RESEARCH
- SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
- (2008) A. Vultur et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation